These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32299149)

  • 1. Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay.
    Kawamori D
    J Diabetes Investig; 2020 Sep; 11(5):1123-1125. PubMed ID: 32299149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
    Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Preserved" glucagon secretion in fulminant type 1 diabetes.
    Murase-Mishiba Y; Bessho-Tachibana M; Imagawa A
    J Diabetes Investig; 2019 Jan; 10(1):186-187. PubMed ID: 30411869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
    Farhy LS; McCall AL
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
    Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2014 Aug; 51(4):567-75. PubMed ID: 24442427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels.
    Gar C; Haschka SJ; Kern-Matschilles S; Rauch B; Sacco V; Prehn C; Adamski J; Seissler J; Wewer Albrechtsen NJ; Holst JJ; Lechner A
    Diabetologia; 2021 Mar; 64(3):512-520. PubMed ID: 33275161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon and type 2 diabetes: the return of the alpha cell.
    Lund A; Bagger JI; Christensen M; Knop FK; Vilsbøll T
    Curr Diab Rep; 2014 Dec; 14(12):555. PubMed ID: 25344790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
    Cooperberg BA; Cryer PE
    Diabetes Care; 2009 Dec; 32(12):2275-80. PubMed ID: 19729529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
    Thivolet C; Marchand L; Chikh K
    Diabetologia; 2019 Apr; 62(4):593-597. PubMed ID: 30612138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible contribution of taurine to distorted glucagon secretion in intra-islet insulin deficiency: a metabolome analysis using a novel α-cell model of insulin-deficient diabetes.
    Bessho M; Murase-Mishiba Y; Imagawa A; Terasaki J; Hanafusa T
    PLoS One; 2014; 9(11):e113254. PubMed ID: 25393115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The α-cell in diabetes mellitus.
    Gromada J; Chabosseau P; Rutter GA
    Nat Rev Endocrinol; 2018 Dec; 14(12):694-704. PubMed ID: 30310153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic α-cells - The unsung heroes in islet function.
    Wendt A; Eliasson L
    Semin Cell Dev Biol; 2020 Jul; 103():41-50. PubMed ID: 31983511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: The role of glucagon in postprandial hyperglycemia--the jury's still out.
    Bollyky J; Greenbaum CJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2879-81. PubMed ID: 17682088
    [No Abstract]   [Full Text] [Related]  

  • 15. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
    Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G
    J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells.
    Honzawa N; Fujimoto K; Kitamura T
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
    Merino B; Casanueva-Álvarez E; Quesada I; González-Casimiro CM; Fernández-Díaz CM; Postigo-Casado T; Leissring MA; Kaestner KH; Perdomo G; Cózar-Castellano I
    Diabetologia; 2022 Aug; 65(8):1375-1389. PubMed ID: 35652923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrinology of islets and the paracrinopathy of diabetes.
    Unger RH; Orci L
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16009-12. PubMed ID: 20798346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postglucagon evolution of blood glucose, a test for treatment stabilization and prognosis in diabetes mellitus].
    Tacu V; Blum M; Tudor G; Dumitriu I; Dinu A; Năstasă V; Ababei V
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(2):247-51. PubMed ID: 3187231
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term changes in pancreatic α-cell function after the onset of fulminant type 1 diabetes.
    Takahashi N; Chujo D; Tsujimoto T; Kajio H
    J Diabetes Investig; 2018 May; 9(3):636-637. PubMed ID: 29750106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.